Zobrazeno 1 - 10 of 152 pro vyhledávání: '"PH Rao"'
1
Use of Drugs and Cost of Treatment of Diarrhea in Secondary Level Government Hospitals in Maharashtra
Autor: PH Rao, SG Kabra
Publikováno v: Indian Journal of Pharmaceutical Sciences
A prescription audit was carried out among the outpatient attendees of 31 secondary level hospitals under Maharashtra Health Systems Development Project. Use of drugs and cost of treatment of diarrhoea were studied using the prescriptions for diarrho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209b99d554c36eea527677ca5312592e
http://europepmc.org/articles/PMC3003182
Zobrazit plný text záznamu
2
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
Autor: E Cesarman, PS Moore, PH Rao, G Inghirami, DM Knowles, Y Chang
Publikováno v: Blood. 86:2708-2714
Two unique DNA fragments were recently identified in over 90% of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma tissues. Sequence analysis suggests that these fragments belong to a previously unidentified human herpesvirus, Kaposi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ca5d8fc0d938baa2f421a84bc4bb44c
https://doi.org/10.1182/blood.v86.7.2708.bloodjournal8672708
Zobrazit plný text záznamu
3
Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma
Autor: Gianluca GAIDANO, Rs, Hauptschein, Nz, Parsa, Offit K, Ph, Rao, Lenoir G, Dm, Knowles, Rs, Chaganti, Dalla-Favera R
Publikováno v: Europe PubMed Central
The recurrent loss of genetic material from a specific chromosomal region in a given tumor type suggests the presence of a tumor- suppressor gene, the loss or inactivation of which may be relevant for tumorigenesis. In this study, we provide molecula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf033f3dab342c90a27edec59d09f52
https://doi.org/10.1182/blood.v80.7.1781.1781
Zobrazit plný text záznamu
4
Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia
Autor: Susana C. Raimondi, James R. Downing, Susan Mathew, James Dalton, PH Rao
Publikováno v: Leukemia. 15(3)
We used a recently described molecular cytogenetic method, spectral karyotyping (SKY), to analyze metaphase chromosomes from 30 pediatric patients with acute lymphoblastic leukemia (ALL). This group included 20 patients whose leukemic blast cells lac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678f53d790d202e066c976cca72c9bd6
https://pubmed.ncbi.nlm.nih.gov/11237073
Zobrazit plný text záznamu
6
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract
Autor: Pasche B, Luo Y, Ph, Rao, Sd, Nimer, Dmitrovsky E, Caron P, Luzzatto L, Offit K, Cordon-Cardo C, Renault B, Jm, Satagopan, Vv, Murty, Joan Massague
Publikováno v: Europe PubMed Central
In a search for mutations of the type I transforming growth factor beta receptor (TbetaR-I), we mapped the gene to 9q22 and found a common polymorphism [TbetaR-I(6A)] and a rare variant [TbetaR-I(10A)] of TbetaR-I, causing an in-frame deletion of thr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::94133831afc836a1290ace60e0c320eb
http://europepmc.org/abstract/med/9661882
Zobrazit plný text záznamu
7
Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors
Autor: Ph, Rao, Houldsworth J, Nallasivam Palanisamy, Vv, Murty, Ve, Reuter, Rj, Motzer, Gj, Bosl, Rs, Chaganti
Publikováno v: Europe PubMed Central
Chemotherapy resistance of tumors is an important biological and clinical problem. Studies from many tumor types have indicated that resistance may be based on multiple genetic pathways. Human male germa cell tumors (GCTs) are an especially good mode
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::43c6e0e486657b23340ac26e7d4c2d7b
http://europepmc.org/abstract/med/9766648
Zobrazit plný text záznamu
8
Editorial & Opinion
Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression.
Autor: Chen Wongworawat Y; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Eskandari G; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA., Gaikwad A; Texas Children's Cancer Center Laboratories, Texas Children's Hospital, Houston, TX, USA., Marcogliese AN; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Ferguson LS; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Brackett J; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA., Punia JN; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Elghetany MT; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Kulkarni R; Texas Children's Cancer Center Laboratories, Texas Children's Hospital, Houston, TX, USA., Rao PH; Texas Children's Cancer Center Laboratories, Texas Children's Hospital, Houston, TX, USA., Ringrose J; Texas Children's Cancer Center Laboratories, Texas Children's Hospital, Houston, TX, USA., Lopez-Terrada DH; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA.; Texas Children's Cancer Center Laboratories, Texas Children's Hospital, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA., Roy A; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA., Curry CV; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA., Fisher KE; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology, Texas Children's Hospital, Houston, TX, USA.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 462-467. Date of Electronic Publication: 2022 Nov 08.
Zobrazit plný text záznamu
9
Akademický článek
LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination.
Autor: Tsang SV; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA.; Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, TX, 77030, USA., Rainusso N; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA.; Dan L. Duncan Cancer Comprehensive Center, Baylor College of Medicine, Houston, TX, 77030, USA., Liu M; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Nomura M; Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Patel TD; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Nakahata K; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA.; Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan., Kim HR; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Huang S; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA., Rajapakshe K; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Coarfa C; Dan L. Duncan Cancer Comprehensive Center, Baylor College of Medicine, Houston, TX, 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, TX, 77030, USA., Man TK; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Rao PH; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA., Yustein JT; Texas Children's Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Dan L. Duncan Cancer Comprehensive Center, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, TX, 77030, USA. yustein@bcm.edu.; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA, 30322, USA. yustein@bcm.edu.
Publikováno v: Oncogene [Oncogene] 2022 Dec; Vol. 41 (50), pp. 5373-5384. Date of Electronic Publication: 2022 Nov 08.
Zobrazit plný text záznamu
10
Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer.
Autor: Liu Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang X; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han C; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wan G; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; School of Life Science and Technology, ShanghaiTech University, Shanghai, China., Ivan C; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang D; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez-Aguayo C; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lopez-Berestein G; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rao PH; Department of Paediatrics, Baylor College of Medicine, Houston, TX, USA., Maru DM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pahl A; Heidelberg Pharma GmbH, Ladenburg, Germany., He X; Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA., Sood AK; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Gynaecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ellis LM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Anderl J; Heidelberg Pharma GmbH, Ladenburg, Germany., Lu X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. xiongbinlu@gmail.com.; Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. xiongbinlu@gmail.com.
Publikováno v: Nature [Nature] 2021 Sep; Vol. 597 (7875), pp. E6.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje